|
Volumn 11, Issue 2, 2005, Pages
|
Face transplantation: Part II - An ethical perspective
|
Author keywords
Bioethics; Human experimentation; Informed consent; Transplantation
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
BASAL CELL CARCINOMA;
CANCER;
CUSHING SYNDROME;
CYTOMEGALOVIRUS INFECTION;
DIABETES MELLITUS;
EPSTEIN BARR VIRUS B CELL LYMPHOPROLIFERATIVE DISORDER;
ETHICS;
FACE SURGERY;
FACE TRANSPLANTATION;
GRAFT REJECTION;
HERPES VIRUS INFECTION;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
INFORMED CONSENT;
LONG TERM CARE;
LYMPHOPROLIFERATIVE DISEASE;
MEDICAL DECISION MAKING;
MEDICAL SOCIETY;
METABOLIC DISORDER;
MICROSURGERY;
MYCOSIS;
OPPORTUNISTIC INFECTION;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
RECURRENT DISEASE;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SKILL;
SKIN INFECTION;
SQUAMOUS CELL CARCINOMA;
TINEA;
TRANSPLANTATION;
TREATMENT INDICATION;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
HEALTH CARE AND PUBLIC HEALTH;
FACE;
HUMANS;
QUALITY OF LIFE;
RISK ASSESSMENT;
SELF CONCEPT;
SURVIVAL;
TISSUE TRANSPLANTATION;
TRANSPLANTATION;
|
EID: 13844275141
PISSN: 12341010
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (25)
|
References (23)
|